A discussion with LaShyra “Lash” Nolen, founding executive director of the We Got Us Empowerment Project and president of her medical school class at Harvard Medical School, about how she’s empowering Black communities to make decisions about COVID vaccines by providing accurate, culturally sensitive information in unique ways.
Read MoreDiscussion with AMA’s Director of Science, Medicine and Public Health, Andrea Garcia to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering third dose vaccines for the immunocompromised, vaccine recommendations for pregnant people, and state-level approaches for students headed back to school this fall.
Read MoreA discussion with Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development about COVID-19’s origin story and why it matters.
Read MoreDiscussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering the rapidly spreading Delta variant, state-by-state mask recommendations
Read MoreA discussion with Dr. Sandra Fryhofer, the AMA’s liaison to the CDC’s Advisory Committee on Immunization Practices (ACIP), who takes a closer look at the delta variant and other variants of concern. She also covers what physicians need to know about authorized COVID vaccines, including real-world effectiveness and rare adverse events.
Read MoreDiscussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering «National Month of Action» and state-by-state vaccination progress, as well as the Delta virus variant.
Read MoreDiscussion with AMA’s Chief Health and Science Officer, Dr. Mira Irons, to review COVID-19 numbers and trending topics related to the pandemic over the past week. Also covering AstraZeneca news, importance of risk mitigation for spring and summer, as well as state-by-state vaccine availability and rollouts.
Read More
Comentarios recientes